Trajectories of Relapse in Randomised, Placebo-Controlled Trials of Treatment Discontinuation in Major Depressive Disorder: An Individual Patient-Level Data Meta-Analysis

Author(s): 

Ralitza Gueorguieva, Adam M. Chekroud, John H. Krystal

ISPS ID: 
ISPS17-05
Full citation: 
Gueorguieva, Ralitza, Adam M Chekroud, John H Krystal (2017) Trajectories of Relapse in Randomised, Placebo-Controlled Trials of Treatment Discontinuation in Major Depressive Disorder: An Individual Patient-Level Data Meta-Analysis. Lancet Psychiatry, Published Online February 8, 2017. DOI: 10.1016/S2215-0366(17)30038-X.
Abstract: 
Introduction: Understanding patterns of relapse in patients who respond to antidepressant treatment can inform strategies for prevention of relapse. We aimed to identify distinct trajectories of depression severity, assess whether similar or different trajectory classes exist for patients who continued or discontinued active treatment, and test whether clinical predictors of trajectory class membership exist using pooled data from clinical trials.
Supplemental information: 

Link to article here.

Publication date: 
2017
Publication type: 
Publication name: 
Discipline: 
Area of study: